Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02521831Phase 3Withdrawn
Phase 3, randomised, double-blind trial of bupivacaine and isoflurane in inguinal hernia (2 arms). Primary endpoint: Change in proinflammatory miRNAs. Planned start Oct 2015; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02521831.